HFA Premium Access

Prevalence of adverse prognostic factors at diagnosis of pulmonary hypertension

Congress Presentation

About the speaker

Doctor Augusto Maria Lavalle Cobo

Sanatorio Finochietto, Buenos Aires (Argentina)
0 follower

6 more presentations in this session

Angiotensin-converting enzyme inhibitors, angiotensin-II receptor antagonists, beta-blockers and ivabradine as supportive therapy in pulmonary hypertension: drug safety and tolerability

Speaker: Doctor S. Zicchino (San Severo, IT)


Right ventricle systolic remodeling index is a new echocardiography parameter that predicts long time survival in patients with pulmonary hypertension

Speaker: Professor O. Aguirre Zurita (Lima, PE)


Exercise-induced oxygen desaturation in patients with idiopathic pulmonary arterial hypertension

Speaker: Professor S. Kucukoglu (Istanbul, TR)


Accuracy and precision of systolic pulmonary pressure assessed by echocardiography among patients with pulmonary hypertension

Speaker: Doctor A. Lescano (Quilmes, AR)


Right ventricle characterization in patients with severe pulmonary hypertension due to post tricuspid shunts in contrast with other etiologies.

Speaker: Professor O. Aguirre Zurita (Lima, PE)


Access the full session

Poster Session 3 - Pulmonary hypertension

Speakers: Doctor A. Lavalle Cobo, Doctor S. Zicchino, Professor O. Aguirre Zurita, Professor S. Kucukoglu, Doctor A. Lescano...

About the event



21 May - 24 May 2016

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb